Summary & Overview
HCPCS G9217: PCP Prophylaxis Not Prescribed After CD4 <200
HCPCS Level II code G9217 documents when PCP (Pneumocystis pneumonia) prophylaxis was not prescribed within three months after a patient’s CD4+ count fell below 200 cells/mm3 and no reason was recorded. The code captures a specific care gap relevant to HIV management and quality measurement, informing clinicians and payers about potential missed opportunities to prevent serious opportunistic infections. Nationally, use of this code signals attention to prophylaxis adherence and documentation practices in ambulatory HIV care.
This analysis covers major national payers including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find context on the clinical intent of the code, the settings where it is typically applied, and the types of benchmarks and policy considerations that are commonly reviewed when assessing prophylaxis prescribing and documentation. The publication summarizes common use cases for the code, implications for quality measurement and reporting, and where data limitations exist.
Topics addressed include benchmarking approaches for measuring prophylaxis prescribing, implications for payer quality programs, and the clinical context of CD4 monitoring and PCP prevention. Data not available in the input are noted where applicable, and no clinical recommendations are provided.
Billing Code Overview
HCPCS Level II code G9217 indicates that PCP prophylaxis was not prescribed within 3 months of a low CD4+ cell count below 200 cells/mm3, reason not given. This code documents a gap in prescribing indicated prophylactic medication for patients with severely low CD4+ counts.
-
Service type: Quality measurement / care gap documentation related to HIV care and opportunistic infection prophylaxis
-
Typical site of service: Outpatient clinic or ambulatory care setting where HIV monitoring and medication management occur
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 42-year-old person living with HIV who presents to an HIV specialty clinic after recent laboratory results show a CD4+ T-lymphocyte count of 180 cells/mm3. The clinician documents that prophylaxis for Pneumocystis jirovecii pneumonia (PCP) was not prescribed within three months of the CD4+ falling below 200 cells/mm3, and no reason for omission is recorded. Clinical workflow begins with routine lab monitoring, notification of the treating clinician when CD4+ thresholds are crossed, medication reconciliation and assessment for contraindications to standard PCP prophylaxis (for example, sulfa allergy or drug interactions). Normally, the next steps would include counseling the patient, ordering a prescription for first-line prophylaxis (commonly trimethoprim-sulfamethoxazole), or documenting a clear, medically justified alternative or documented contraindication. In this scenario, the absence of a documented reason within three months triggers use of billing code G9217 to indicate prophylaxis was not prescribed and the rationale was not provided.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure or other service | Use when a distinct E/M visit is provided the same day another service or procedure is reported related to HIV care. |